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Reexamining the Hypoglycemia Fear Survey
for Parents of Young Children in a Sample of Children
Using Insulin Pumps
Susana R. Patton, PhD, CDE,1,2 Amy E. Noser, MS,2,3 Mark A. Clements, MD, PhD,2,4
Lawrence M. Dolan, MD,5 and Scott W. Powers, PhD, ABPP6

Abstract

Background: We update the psychometric properties of the Hypoglycemia Fear Survey-Parents of Young
Children (HFS-PYC), a 26-item measure of parents’ hypoglycemia fear for young children using an insulin
pump.
Methods: We combined three similar datasets for the analyses. The data analyzed included parents’ responses
to the HFS-PYC and a demographic form. For a subset of children (n = 91), we also analyzed self-monitoring of
blood glucose data. We used confirmatory factor analysis (CFA) to confirm the measure’s original factor
structure. Additional analyses examined reliability and validity of a revised HFS-PYC for parents of young
children using pumps.
Results: We analyzed data from 116 parents (93% mothers). Mean child age and HbA1c were 5.2 – 1.3 years
and 8.2% – 1.1%, respectively. CFA identified a 22-item two-factor solution (v2 (208, n = 116) = 368.688,
P < 0.001, root mean square error of approximation = 0.08, comparative fit index = 0.94, and Tucker-Lewis
index = 0.93) with factors corresponding to the original subscales: worry and behavior. The revised subscales
demonstrated at least adequate internal consistency (Cronbach’s alpha >0.65). Correlations revealed significant
negative associations between current HFS-PYC worry scores and children’s mean daily blood glucose and
percent of very high glucose levels per day, suggesting less fear among parents of young children with elevated
glycemic levels. In addition, there was a positive association with the percent of glucose levels in target,
suggesting greater hypoglycemia fear among parents of children who have better control.
Conclusions: Results provide preliminary evidence for the reliability and validity of a reduced 22-item HFSPYC for parents of children using insulin pumps.
Keywords: Hypoglycemia, Type 1 diabetes, Insulin pumps, Pediatrics, Continuous subcutaneous insulin
infusion.

Introduction

H

ypoglycemia is a common acute complication of insulin management in patients with type 1 diabetes (T1D).1,2
Hypoglycemia is potentially dangerous because it can lead to
uncomfortable counter-regulatory symptoms such as head-

aches, dizziness, confusion, irritability, weakness, sweating,
a racing pulse, and neuroglycopenia.1,3–5 Moreover, in young
children (<8 years old), repeated episodes of hypoglycemia
have been linked to at least transient problems with attention
management, information processing, and executive functioning.6 Due to their heightened sensitivity to insulin, erratic
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eating behaviors, unpredictable activity levels, and difficulty in
recognizing or reporting symptoms, young children tend to be
highly susceptible to episodes of hypoglycemia. The latter can
negatively impact their parents, who commonly report fear of
hypoglycemia (FH).5
FH is a term used to describe severe anxiety-like symptoms related to glucose management as well as the use of
hypoglycemic avoidance behaviors.5,7–9 Past research suggests that FH is reported by up to 60% of parents of young
children based on self-report using the Hypoglycemia Fear
Survey-Parents of Young Children (HFS-PYC).8,9
The HFS-PYC is a reliable and valid measure of FH
adapted from an existing adult questionnaire, the Hypoglycemia Fear Survey.9,10 In the development phase of the HFSPYC, a five-member panel of diabetes care providers (e.g.,
one physician, one nurse educator, one dietitian educator, and
two psychologists) reviewed potential items to ensure good
content validity. Then, a preliminary form of the HFS-PYC
was administered to a sample of parents of young children
with T1D to determine its initial psychometrics.9
However, one challenge to ongoing use of the HFS-PYC is
that it was originally tested in a sample of children who were
70% conventionally managed for insulin because that was
still a primary insulin regimen at the time. Now, data from the
T1D Exchange suggest that *69% of young children use an
insulin pump for daily management,11 but an updated evaluation of psychometric properties of the HFS-PYC in a
sample of parents of children using a pump has not been
published. Thus, the purpose of this study was to use confirmatory factor analysis (CFA) to confirm the psychometrics
of the HFS-PYC in a sample of parents with children who use
an insulin pump for their daily treatment.
Methods

Data were compiled from three projects, completed over 5
years, which recruited young children with T1D and a parent.
For all three projects, the inclusion/exclusion criteria were
similar. Families were eligible if they had a child with T1D who
was between the ages of 1–7 years, their child had T1D for at
least 6 months before study enrollment, their child used an
insulin pump for daily management, and the family spoke
English. Families were ineligible to participate in any of the
three projects if their child had some other form of diabetes,
their child had a chronic condition in addition to T1D that might
further complicate their child’s medical management (e.g.,
kidney disease), or if their child was taking any medications
that could disrupt glycemic control (e.g., systemic steroids).
Before combining the samples, we compared the studies
and found no differences in their demographics or parents’
hypoglycemia fear scores, suggesting that it was acceptable
to proceed with the new larger data set. It was necessary to
have this larger data set to proceed with a CFA of the HFSPYC.12
Procedure

For all three projects, we obtained appropriate institutional
review board approval from each of the participating hospitals ahead of subject enrollment.
To enroll eligible families, a member of the research team
contacted families by telephone or in person during routine
diabetes clinic visits. During enrollment, we explained each
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study, answered questions, and completed the informed
consent. Families then completed a series of questionnaires,
which included a demographic form and the HFS-PYC.8,9 In
all cases, we obtained a measure of the child’s most recent
glycated hemoglobin (HbA1c) from his/her medical chart. In
a subset of children (n = 91), we also collected at least 14 days
of self-monitoring blood glucose data from children’s glucometers to calculate measures of glycemic variability. Parents who participated were reimbursed between $25 and $50,
depending on each study’s protocol.
Measures
Hypoglycemia fear survey-parents of young children9. This
is a 26-item questionnaire that was modified from the
Hypoglycemia Fear Survey-Parent (HFS-P)7 to make it
more appropriate for use with parents of children with T1D
who are less than 8 years old. Similar to the HFS-P, the
HFS-PYC was developed to yield two subscales, the worry
subscale, which assesses parents’ fear and worry related to
the occurrence of a low blood glucose event for their child,
and the behavior subscale, which measures parents’ behaviors related to preventing a low blood glucose event. For
each item, parents respond using a five-point Likert scale
(1 = never, 5 = very often). Subscale scores are then obtained
by tallying the items corresponding to either the worry (16
items expected) or behavior (10 items expected) subscales.
Demographic and medical history form. Parents reported
on demographic characteristics of their child (e.g., age, sex,
time since diagnosis) and themselves (e.g., relationship with
their child and marital status), and provided the necessary
information to estimate the families’ socioeconomic level
(e.g., parents’ education and employment).
Analysis

We conducted our CFA using Mplus Version 7.31.13 Before conducting our CFAs, we screened the data for outliers
and violations of normality and one item (item #8 Always
carry fast-acting sugar) fell beyond the recommended
guidelines for skewness (-3.713) and kurtosis (14.195),
suggesting that this item may not differentiate among individuals in this population and therefore was omitted from all
subsequent analyses.
We then specified a two-factor measurement model based
on the original factor structure of the HFS,10 allowing latent
factors to correlate freely. Because the items used a five-point
Likert scale, we modeled all items as ordinal data using the
weighted least-squares mean and variance-adjusted estimation.14,15 We examined multiple fit indices to evaluate model
fit: chi-square (v2), the comparative fit index (CFI), the
Tucker-Lewis index (TLI), and the root mean square error of
approximation (RMSEA). CFI and TLI values range from 0
to 1; values >0.90 indicate an acceptable model fit and values
>0.95 indicate a good model fit.16,17 The RMSEA represents
population error variance, with values between 0.08 and 0.05
indicative of an acceptable model fit and values <0.05 indicative of good fit.17,18
We used SPSS Version 2219 to examine internal consistency of the final model subscales and full scale, associations
between HFS-PYC subscales and daily average blood glucose, and comparisons with published research.
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Results
Participants

There were 116 child–parent dyads in our sample (93%
mothers). The sample of children had a mean age of 5.2 – 1.3
years (range, 2.0–7.9). Fifty percent of the children were
male, 91% were described by their parent as non-Hispanic
white, and all children used an insulin pump for daily diabetes care. At the time of data collection, the HbA1c target in
children <6 years old was between 7.5% and 8.5% and it was
£8% in children 6–12 years old.1 The HbA1c values for the
present sample of children ranged from 5.70% to 12.70%
(M = 8.2% – 1.1%; 40.5% of HbA1c values were in the recommended range).
Confirmatory factor analysis

The initial CFA model, using 25 items of the original HFSPYC, demonstrated an acceptable fit to the data, v2 (274,
n = 116) = 423.292, P < 0.001, RMSEA = 0.07, CFI = 0.94,
and TLI = 0.94. However, standardized factor loadings for
three items fell below 0.30: items 2 (‘‘Avoid allowing my
child to be away from me/in someone else’s care when his/
her sugar is likely to be low,’’ standardized loading = 0.07,
P = 0.59), 5 (‘‘Feed my child as soon as I feel or see the first
signs of a low blood sugar,’’ standardized loading = 0.22,

FIG. 1. The confirmatory factor analysis
results for the Hypoglycemia Fear SurveyParents of Young Children (HFS-PYC) in
parents of young children who are using an
insulin pump. All standardized path coefficients are significant at P < 0.01.
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P = 0.02), and 9 (‘‘Keep my child quiet if I think his/her blood
sugar could go low (i.e., avoid hard play or activity),’’ standardized loading = 0.16, P = 0.15). Thus, we removed these
items and conducted a subsequent CFA. Results of this
CFA revealed an acceptable fit for the 22-item two-factor
model: v2 (208, n = 116) = 368.688, P < 0.001, RMSEA =
0.08, CFI = 0.94, and TLI = 0.93 and standardized factor
loadings ranged between 0.32 and 0.83. The factor loadings
for the final two-factor model are presented in Figure 1.
Reliability and validity

With items 2, 5, 8, and 9 removed based on the CFA results, we examined the reliability and validity of an updated
HFS-PYC. The updated HFS-PYC worry subscale (a = 0.92)
demonstrated excellent internal consistency, whereas the
HFS-PYC behavior subscale demonstrated an internal consistency in the lower acceptable range (a = 0.68). Correlations
between the HFS-PYC factors indicated that they are related,
but distinct, constructs (Fig. 1). The HFS-PYC worry subscale negatively correlated with children’s average daily
blood glucose (r = -0.267, P = 0.01) and the percent of very
high glucose levels (>250 mg/dL; r = -0.227, P = 0.03).
However, the HFS-PYC worry subscale positively correlated
with the percent of glucose levels between 70 and 180 mg/dL
(r = 0.274, P = 0.008), suggesting greater FH in parents of
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children who are in better glycemic control. There were no
correlations between the updated six-item HFS-PYC behavior subscale and children’s glucose levels.
HFS score comparisons with published outcomes

Calculating subscale scores using the reduced 22-item
HFS-PYC, parents in the present sample reported a mean
worry score of 45.2 – 14.2 and a mean behavior score of
17.2 – 4.1. However, to allow for comparisons with published
scores,7–10 we adjusted for the number of subscale items by
calculating a mean item score for each subscale, yielding a
mean item score of 2.8 – 0.88 for the worry subscale and a
mean item score of 2.9 – 0.69 for the behavior subscale.
Using the mean item scores and a series of one-sample ttests with unequal variances, results showed significantly
higher worry scores for parents in the present sample when
compared with mothers of conventionally managed young
children9 and adult patients with T1D (P’s £ 0.01).10 There
was also a trend found suggesting higher worry scores for
parents in the present sample when compared with published
data from mothers of preadolescent youth (P = 0.07).7 For the
behavior score, parents in the present sample reported higher
mean item scores than did adult patients (P £ 0.001), but
lower mean item scores than mothers of conventionally
managed young children and mothers of preadolescent youth
(P £ 0.001).
Discussion

The HFS-PYC is the only available measure of FH for
parents of young children. However, until now, there were no
data available establishing its measurement properties in a
sample of parents of young children using an insulin pump.
Study findings indicated that for this parent population, a
two-factor structure corresponding to parents’ behaviors and
worries surrounding hypoglycemia best captures FH. These
results also suggest that four original items from the behavior
subscale may not contribute to the measurement of parental
FH in young children on pump therapy. For instance, one
item (i.e., item #8) demonstrated significant negative skew,
suggesting that this item may not differentiate elevated FH
from more typical levels in parents of young children using
pump therapy. Furthermore, insufficient factor loadings for
items 2, 5, and 9 indicate that these items may not provide
meaningful information for the measures of FH in the current
population. Interestingly, in a recent study with parents and
adolescents with T1D, researchers identified a two-factor
structure within the HFS behavior subscale corresponding to
potentially adaptive (e.g., ‘‘Avoid being alone when blood
glucose could drop’’) versus maladaptive (e.g., ‘‘Try to run
blood sugars a little high to be safe’’) behaviors.20 Although
we did not directly test for these subfactors in our analyses,
items 2, 5, and 9 do reflect potentially adaptive behaviors to
prevent low blood glucose, which may explain why they did
not load on a factor that also included potentially maladaptive
behaviors. Thus, as a future study, it may be important to
confirm if a two-subfactor structure exists for the HFS-PYC
behavior scale in a larger sample of parents.
Overall, for the present sample, the HFS-PYC demonstrated good internal consistency. The HFS-PYC behavior
subscale had the lowest internal consistency, which could be
attributed to a limited number of items (i.e., 6 vs. 16 items).
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However, it is notable that previous studies using the 10-item
version of this subscale report comparable internal consistency values (e.g., 0.62 and 0.70).8,9 Furthermore, studies
using the HFS and HFS-P also report lower internal consistency for the behavior subscale.7,10 Thus, it is also possible
that this subscale is not as sensitive to behaviors indicative of
FH because it combines both adaptive and maladaptive behaviors to prevent low blood glucose.20
As a measure of validity, we correlated our modified HFSPYC questionnaire with children self-monitoring blood glucose levels. While previous research has been inconsistent
regarding the association between parents’ FH and children’s
glycemic control,5,8,9 our findings revealed that the HFSPYC worry subscale was negatively associated with children’s average daily blood glucose and the percent of very
high glucose levels and positively associated with the percent
of blood glucose levels in the target range. It is possible we
were able to measure these associations, while past research
was not, because we employed a very specific definition of
target blood glucose according to Bergenstal et al.’s21 recommendations for standardizing glucose reporting. However,
it is also possible parents of children with higher blood glucose reported less worry because they purposely allowed
their child to run above target as a way to reduce the chance of
low blood glucose and their fear of a low, suggesting that a
more complicated association between parents’ FH and
children’s glycemic control may exist. Because these were
correlations, cause and effect cannot be determined. Therefore, one recommendation for the future would be a longitudinal study to see if a temporal relationship between
parents’ FH and children’s glycemic levels could potentially
unravel the nature of this association.
A comparison of parents’ scores on the HFS-PYC behavior
and worry subscales with published scores yielded mixed
results. Higher worry scores for current study parents when
compared with parents of preadolescent youth22 and adult
patients with T1D22 may be explained by young children’s
difficulties with reporting symptoms of hypoglycemia due to
cognitive and communication immaturity as well as their
greater susceptibility to glycemic variability.1 In contrast,
parents in the present study may have reported higher worry
scores than mothers of conventionally managed young
children22 because the pump may prevent their child from
experiencing as much glycemic variability as conventionally
managed children do, leading to parents of children on pumps
having less experience and lower confidence in managing
hypoglycemia successfully and higher fear.23,24 Interestingly, consistent with previous research using the HFS-P,25
we found that parents of young children on pumps reported
lower mean scores on the HFS-PYC behavior subscale
compared with parents of conventionally managed young
children.22 One possible explanation for this finding is the
increased flexibility of pump therapy, which allows parents to
make insulin adjustment more easily and to reduce reliance
on behaviors that may overcompensate for hypoglycemia,
such as feeding large snacks.26–28
Limitations and future directions

Limitations of our study include the homogeneity of our
sample and our cross-sectional design. Because the majority
of the study sample included families of young children who
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self-identified as non-Hispanic white, the study results may
not generalize to parents from other racial or ethnic backgrounds. However, because the study sample has a racial/
ethnic diversity similar to that of the US population of youth
with T1D,29 we expect our modified HFS-PYC will be applicable to the majority of parents of young children with
T1D and future research can investigate its psychometric
properties in a more racially or ethnically diverse sample.
Since we were limited to cross-sectional data, we cannot
assess test-retest reliability of our modified HFS-PYC, nor
examine the temporal association between parents’ HFSPYC scores and children’s glycemic levels. However, both of
these questions can be addressed in a future longitudinal
study as well as measuring for other forms of validity such as
convergent and divergent validity.
Conclusion

This study provides support for use of a modified version
of the HFS-PYC in parents of young children on insulin pump
therapy. Our results show that the original two-factor structure of the HFS-PYC fits the data well, with the removal of
four items from the behavior subscale. Therefore, we recommend that researchers and clinicians who use the HFSPYC in parents of young children on insulin pumps consider
removing these items when calculating the behavior subscale
and total score. Additionally, we encourage researchers to
conduct further assessment of the validity of the HFS-PYC to
better establish its psychometric properties.
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